Skip to main content

Research Repository

Advanced Search

Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors

Hu, Zhaoxin; Zhou, Shengnan; Li, Junda; Li, Xinnan; Zhou, Yang; Zhu, Zheying; Xu, Jinyi; Liu, Jie

Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors Thumbnail


Authors

Zhaoxin Hu

Shengnan Zhou

Junda Li

Xinnan Li

Yang Zhou

ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
Associate Professor in International Pharmacy and Traditional Medicines

Jinyi Xu

Jie Liu



Abstract

Aim: Based on a multitarget design strategy, a series of novel indanone-1-benzyl-1,2,3,6-tetrahydropyridin hybrids were identified for the potential treatment of Alzheimer's disease (AD). Results: These compounds exhibited significant inhibitory activities against acetylcholinesterase (AChE) and moderate inhibitory activities toward monoamine oxidase B (MAO-B). The optimal compound A1 possessed excellent dual AChE/MAO-B inhibition both in terms of potency (AChE: IC50 = 0.054 ± 0.004 μM; MAO-B: IC50 = 3.25 ± 0.20 μM), moderate inhibitory effects on self-mediated amyloid-β (Aβ) aggregation and antioxidant activity. In addition, compound A1 exhibited low neurotoxicity. More importantly, compound A1 showed significant cognitive and spatial memory improvements in the scopolamine-induced AD mouse model. Conclusion: All results suggest that compound A1 may become a promising lead of anti-AD drug for further development.

Citation

Hu, Z., Zhou, S., Li, J., Li, X., Zhou, Y., Zhu, Z., …Liu, J. (2023). Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors. Future Medicinal Chemistry, 15(20), 1823-1841. https://doi.org/10.4155/fmc-2023-0206

Journal Article Type Article
Acceptance Date Sep 18, 2023
Online Publication Date Oct 30, 2023
Publication Date Oct 30, 2023
Deposit Date Nov 23, 2023
Publicly Available Date Jan 31, 2024
Journal Future Medicinal Chemistry
Print ISSN 1756-8919
Electronic ISSN 1756-8927
Publisher Future Science
Peer Reviewed Peer Reviewed
Volume 15
Issue 20
Article Number mc-2023-0206
Pages 1823-1841
DOI https://doi.org/10.4155/fmc-2023-0206
Keywords AChE; Alzheimer's disease; indan-1-one; MAO-B; MTDLs
Public URL https://nottingham-repository.worktribe.com/output/26811870
Publisher URL https://www.future-science.com/doi/full/10.4155/fmc-2023-0206

Files




You might also like



Downloadable Citations